SCHEMBL3759591

SCHEMBL3759591

CC(=O)Oc1ccc(Sc2ccc(C=O)cc2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.39
JUN P05412 1/20 0.39
NFKB1 P19838 1/20 0.39
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 3/20 0.36
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
GFER P55789 1/20 0.36
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 1/20 0.36
VCP P55072 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
TSHR P16473 2/20 0.36
RAB9A P51151 1/20 0.36
AOX1 Q06278 1/20 0.36
CYP3A4 P08684 1/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049324 0.84 LMNA (0.43) ALDH1A1KDM4EGAAGLAGFER
SCHEMBL2391067 0.84 ALDH1A1 (0.55) TTRJUNNFKB1ALDH1A1KDM4E
SCHEMBL2705970 0.82 KDM4E (0.43) ALDH1A1KDM4EGAAGLAGFER
SCHEMBL2705266 0.82 TSHR (0.54) TTRALDH1A1KDM4EGAAHPGD
SCHEMBL12996678 0.79 PARP10 (0.45) TTRJUNNFKB1ALDH1A1KDM4E
SCHEMBL2706311 0.76 CYP3A4 (0.47) TTRALDH1A1KDM4EHPGDMAPT
SCHEMBL11149185 0.75 ELANE (0.36) HPGDL3MBTL1TDP1TSHRKMT2A
SCHEMBL3768957 0.74 KDM4E (0.46) TTRALDH1A1KDM4EHPGDTDP1
SCHEMBL1088564 0.73 JUN (0.44) TTRJUNNFKB1ALDH1A1KDM4E
SCHEMBL31190039 0.72 JUN (0.57) JUNNFKB1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R TTR 3753/4885JUN 2446/4885NFKB1 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.